Editorial Policies

Aims and Scope

Pharmacy is a complex of scientific and practical disciplines that study the problems of creation, safety, research, storage, manufacture, distribution and marketing of medicines, as well as the search for natural sources of medicinal substances.

Pharmacy has been formed throughout the history of human development and science in almost all its areas in many branches of economic activity and continues to develop rapidly. There are new opportunities, approaches and research technologies based on new physical principles and requests of translational medicine with their success in the study of cell biology, normal and pathological human physiology.

Pharmacy cannot progress without the development of organic and inorganic chemistry, physical and mathematical Sciences, engineering, industrial biomedical and pharmaceutical technologies for the creation and production of medicines.

Drugs act on the biochemical processes of the human body. Thanks to the latest scientific achievements in General and clinical biology; physiology and pathophysiology; molecular genetics and epigenetics; endocrinology and toxicology, approaches to the development of new and evaluation of the effectiveness of existing drugs are being improved.

New discoveries in pharmacology and clinical pharmacology allow us to solve problems of pharmacodynamics and pharmacokinetics. The study of the interaction of a combination of drugs with social factors, food and the environment on the body continues.

We hope for long and fruitful discussions among readers of our publication, as well as that the publications will not only be of the nature of transmitting information, but will also be able to engage the reader. This style of simplicity, impact, and effective presentation of material contributes to scientific communication with the outside world and has long been used abroad.

Special attention will be paid to issues related to pharmaceutical safety, which, along with food safety, have become an urgent part of the country's environmental security, along with global problems of nature management and environmental protection. Their solution is of national economic importance, as well as the very provision of medicines to the population.

Sections

From the editor

Pharmaceutical Sciences

The pharmaceutical Sciences section publishes the results of research aimed at: solving scientific and technical problems of these specialties for the national economy and consists in the study of previously unknown patterns in the technology of obtaining medicines; in developing the foundations of the state quality assurance system at all stages of the drug life cycle, pricing methodology in the field of medicines; problems of professional training of pharmaceutical specialists and new information technologies in pharmacy; the study of physical, chemical, and biological properties of medicinal substances and medicinal raw materials, their changes in the process of obtaining, processing, storage, and use, taking into account the influence of various factors (technological, climatic, etc.), as well as developing methods for obtaining, cleaning, standardization, and quality control of medicines in accordance with the codes and formulas of specialties.

Biomedical Sciences

This section publishes the results of research aimed at: studying the interaction of drugs with living systems through chemical mechanisms, by binding to regulatory molecules, activation or inhibition of processes occurring in the body; search and development of new effective medicines for the prevention and treatment of various diseases, for the regulation of the functional state of organs and body systems, research of pharmacodynamics, pharmacokinetics and metabolism of medicines, their interaction, study of the mechanisms of action and manifestation of undesirable side effects, as well as experimental (preclinical) study of the safety of potential medicines; to study the effectiveness and safety of medicines in healthy and sick people, to conduct drug monitoring, to improve pharmacotherapy in various diseases, to study the pharmacogenetics and features of pharmacodynamics, pharmacokinetics and metabolism, as well as the interaction and manifestations of undesirable side effects of medicines in the clinic; study of the interaction of chemicals and living organisms, the causes of poisoning, the behavior of toxicants in the body, their effects on various organs and systems, including offspring and hereditary properties of the body in accordance with the codes and formulas of specialties.

Biological sciences

The biological Sciences section publishes the results of research on the structure and functioning of living systems in space and time under natural and human-modified conditions.

Information and Prevention

Actual problems: discussion tribune

Pharmaceutical learning activit

Heritage

Peer Review Process

All manuscripts submitted to the Editorial Board of the journal are subject to mandatory double-blind peer review (reviewer does not receive information about the authors of the manuscript, the authors of the manuscript do not receive information about the reviewers).

Review of manuscripts is carried out by members of the Editorial Board and the Editorial Council, as well as by invited reviewers — leading experts in the relevant field. The decision on the choice of a reviewer for the examination of the article is made by the editor-in-chief, Deputy editor-in-chief, Executive Secretary. The review Period is 4 weeks, but at the request of the reviewer it can be extended.

Each reviewer has the right to refuse the review in case of a clear conflict of interest affecting the perception and interpretation of the manuscript. Following the review of the manuscript, the reviewer gives recommendations on the future of the manuscript (each decision of the reviewer must be justified):

• to accept the manuscript for publication in the present form;
• to accept the manuscript for publication after correcting the shortcomings noted by the reviewer;
• to reject the manuscript;
• to submit the manuscript to the journal of another profile.

The editorial Board of the journal sends the text of reviews to the author. If there are recommendations for revision of the manuscript, the editorial Board proposes to take them into account when preparing a new version of the manuscript.

In case of disagreement with any recommendations (comments) in the response letter to the reviewers, the authors need to clearly argue the reason for the refusal to make the appropriate corrections (additions).

Revision of the article should not take more than two months from the date of sending an electronic message to the authors about the need to make changes. The manuscript modified by the author will be re-sent for review.

The authors make out the answers to the reviewers in separate files and upload them to the site as additional ones on the "summary" tab at the User page. In the case of absence of such a file, further work with the manuscript is suspended, and the authors are notified accordingly.

In case of refusal of the authors to finalize the materials, they must notify the editorial Board in writing of their refusal to publish the article. If the authors do not return the revised version after three months from the date of sending the review, the editorial Board removes it from the account even in the absence of information from the authors with the refusal to finalize the article. In such situations, the authors will be notified of the withdrawal of the manuscript from registration in connection with the expiration of the period allotted for revision.

The editorial Board conducts no more than three rounds of review for each manuscript. If after double revision of the manuscript the reviewers or the editorial Board still have significant comments, the editorial Board rejects the manuscript and removes it from registration. In this case, the authors are notified accordingly.

If the author and reviewers have any unsolvable contradictions regarding the manuscript, the editorial Board has the right to send the manuscript for additional review.

The decision to refuse to publish the manuscript is made at a meeting of the editorial Board in accordance with the recommendations of the reviewers. The message about refusal in the publication goes to the author by e-mail, in the letter reviews and the bases for refusal in the publication are given. The manuscript, not recommended by the decision of the editorial Board for publication, is not accepted for re-consideration.

The presence of a positive review is not a sufficient basis for the publication of the article. The final decision on the publication is made by the editorial Board. In conflict situations, the decision is made by the editor-in-chief.

After the editorial Board of the journal decides on the admission of the manuscript for publication, the editorial Board informs the author and indicates the date of publication.

Originals of reviews are kept in editorial office not less than 5 years.

Reviews of manuscripts are not published in the public domain and are used only in the internal document circulation of the editorial Board, as well as in communication with the authors.

Publication Frequency

 Pharmacy Formulas - is a quarterly publication. Additional publications are possible, such as conference proceedings, special issues, and additional issues.

Open Access Policy

Publications in the journal are available to everyone from the moment of publication. Thus, this journal provides immediate and open access (in accordance with the Budapest Open Access Initiative) to its content, based on the principle that making research freely available to the public contributes to a broader global knowledge exchange. In addition, the editorial board believes that it provides free access to research results and promotes the development of science and medicine.

All articles are published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license for free distribution and use worldwide.

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.

Author Self-Archiving

The editorial board of the journal allows and even recommends authors to post published articles on their personal pages on the Internet and on the websites of their organizations with a link to the original publication on this site.

Indexation

The journal currently indexed in:

• Google Scholar
• WorldCat

Publishing Standards and Ethics

The journal "Pharmacy Formulas" publishes manuscripts that meet international standards of publication ethics in biomedical journals.

The manuscript will be retracted from publication if at any stage of consideration or prepress editorial Board found a violation of the requirements of publication ethics.

If such a violation is found by readers after the publication of the article, it will be rertracted. This will also entail a one-year ban on future publications in our journal for members of the authors team.

Violations of publication ethics include:

• plagiarism;
• simultaneous submission of manuscripts to several journals;
• concealment of conflict of interest;
• assessment of professional qualities of reviewers;
• illegal co-authorship.

Plagiarism

Plagiarism can take many forms, from presenting someone else's work as an author's work, to copying or rephrasing essential parts of someone else's work (without attribution), or to claiming ownership of someone else's research. Plagiarism in all forms is unethical and unacceptable.

The manuscript authors should submit entirely original work. References to the results of the works of other authors should be accompanied by references to the relevant primary sources (which should be included in the list of references).

Citation of the text, previously published somewhere, should be framed as a DIRECT SPEECH (the text should be enclosed in quotation marks) with the obligatory indication of the source. The inclusion of large fragments of borrowed text in the manuscript is unacceptable.

The contribution of others to the study should always be recognized. Authors should refer to publications that were of great importance in the performance of scientific work covered in the manuscript.

Data obtained informally (e.g. during a conversation, correspondence or discussion with third parties) should not be used or presented without the written permission of the original source.

Information obtained from confidential sources (for example, grant for research) should not be mentioned in the manuscript without the Express written permission of the author of the manuscript, who is directly related to these confidential sources.

Identification of plagiarism is carried out:

• in the process of the peer review;
• using the ANTIPLAGIAT software;
• after the publication of manuscripts-upon the treatment of readers with the relevant statements.

In establishing the fact of plagiarism of the data (results of scientific work) or ideas, the manuscript (article) will be withdrawn and rejected from publication, even if it has already been published. An official notice will be posted on the journal's website.

Simultaneous submission of a manuscript to several journals or submission of already published data under a different title

Identification of the fact of submission of the same manuscript to more than one journal at the same time will be regarded as a violation of publication ethics. The manuscript will be rejected.

Publication of a certain type of articles (for example, translated articles) in some cases is permissible under certain conditions. When submitting a manuscript for secondary publication, the authors should notify the Editorial Board and justify the expediency of such publication in detail. In the case of a secondary publication, the resolution of issues related to copyright for publication is decided on a case-by-case basis. The General rules of the manuscript for the "secondary" publication are:

• full bibliographic reference to the primary publication;
• preservation of the original bibliography of the primary work.

More information on acceptable forms of secondary (repeated) publications can be found on the ICMJE page.

Concealing a conflict of interest

All authors are required to disclose (declare in the relevant section of the manuscript) financial or other obvious or potential conflicts of interest that may be perceived as having an impact on the results or conclusions presented in the work.

Examples of potential conflicts of interest to be disclosed:

• receiving financial reward for participation in research or writing a manuscript;
• any connection (work under the contract, consulting, availability of joint-stock property, receipt of fees, provision of expert opinions) with organizations that have a direct interest in the subject of research or review;
• patent application or registration of a patent for the results of research (copyright, etc.);
• obtaining financial support for any stage of research or manuscript writing (including grants and other financial support).

Information on conflicts of interest received from the authors of the manuscripts will be available only to the Editorial Board when deciding on the publication of the manuscript. Also, information about conflicts of interest is published in the full text of the article.

Assessment of the reviewer's competence

Evaluation of professional qualities of the reviewer is the exclusive prerogative of the Editorial Board.

Attempts by authors to assess the competence of reviewers will lead to rejection of the manuscript.

Unfairly co-authorship.

The authors of the publication can be only those persons who have made a significant contribution to the formation of the idea of the work, development, execution and/or interpretation of the results of the study, as well as to the process of writing the manuscript (including conducting scientific and stylistic editing and design in accordance with the requirements of the journal).

Authors should ensure that:

• all participants who have made a significant contribution to the study are presented as co-Authors;
• those who did not participate in the study are not listed as co-Authors.

Access and storage of raw data

The editors reserve the right to request the Authors of the original (raw) data of the study, including for reviewers and editors. The authors should be ready to provide this kind of information to the editorial staff (according to ALPSP-STM Statement on Data and Databases (link)), as well as to store this data.

Significant errors in published works

In case of significant errors or inaccuracies in the publication, the author should inform the Editorial Board or the Publisher and interact with the Editorial Board in order to remove the publication or correct errors as soon as possible. If the editorial Board or publisher has received reasonable information from a third party that the publication contains significant errors, the author is obliged to withdraw the work or correct errors as soon as possible or to refute the statement of errors by submitting the necessary evidence to the editor.

Publication Fee

Articles in the journal "Pharmacy Formulas" are published free of charge for all authors.

The editorial Board does not charge the authors for placing articles in open access, reviewing, preparing the journal for publication, as well as the content of the site and electronic depositing of manuscripts.

Adverticement and reprint policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

1. The Eco-Vector’s journals generate revenue from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
8. Advertising for the following categories is prohibited:
   
   • Alcohol
   • Tobacco
   • Weapons, firearms, ammunition
   • Fireworks
   • Gambling and lottery
   • Pornography or related themes
   • Political and religious advertisements
   • Advertisements that claim to have a “miracle” cure or method
   • Advertisements that make unsubstantiated health claims for the products advertised
   • Advertisements directed at children
9. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
10. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
11. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
12. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
13. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
14. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
15. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
16. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
17. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
18. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
19. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
20. The following online advertising formats are prohibited:
    
    • Pop-ups and floating advertisements.
    • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
    • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
    • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/

---